…in laymen’s terms what are you predicting or speculating will happen with this condition different from the other three?
GC, sorry, I’m still trying to process all this myself! Perhaps if I reduce this to a few key points.
- We can now have evidence that Neuren, Acadia and Baker Brothers all have some kind of interest in a treatment for Prader-Willi (PW).
- The first to show interest in PW was Baker Brothers (BB) in November 2019. BB invested in and joined the Board of a tiny biotech whose only asset was an investigational treatment for PW.
- Neuren suddenly added the PW indication to its development pipeline in early 2021, almost 2 years after choosing its other 3 indications. I have always had the sense that this late addition of the PW program was driven by outside interest.
- I’m not sure why there have been delays in Neuren commencing the PW trial. Perhaps, as sillazze suggests, we’ll shortly hear that Acadia will join NEU in the development of Prader-Willi? Or perhaps the intention is to allow the other 3 indications to read out first so that, if those studies are a success, their full value would have to be factored in if someone decided to make a move on Neuren post-PW readout.
- The hallmark symptom of hyperphagia (abnormal hunger and excessive eating) is another difference between PW and the other 3 indications. Controlling hyperphagia has been found to be a key goal for PW caregivers. In the preclinical animal testing of NNZ-2591 in PW, at the higher dose, obesity was eliminated and abnormally high insulin levels were reduced to normal (Ref. NEU ASX Ann. 16/02/21). Think about that for a minute.
- Forums
- ASX - By Stock
- NEU
- Ann: Investor Presentation, 14 March 2023
Ann: Investor Presentation, 14 March 2023, page-64
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.42 |
Change
-0.100(0.49%) |
Mkt cap ! $2.641B |
Open | High | Low | Value | Volume |
$20.60 | $20.77 | $20.39 | $2.086M | 101.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 227 | $20.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.43 | 99 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 56 | 20.390 |
5 | 294 | 20.380 |
6 | 253 | 20.370 |
3 | 203 | 20.360 |
3 | 255 | 20.350 |
Price($) | Vol. | No. |
---|---|---|
20.410 | 47 | 3 |
20.420 | 149 | 15 |
20.430 | 160 | 4 |
20.440 | 274 | 5 |
20.450 | 1136 | 10 |
Last trade - 13.42pm 15/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |